Gold Radio’s 2025 schedule will begin next week, with Gallacher presenting from Monday to Thursday from 4pm to 7pm, and Fridays from 4pm to 6pm. Kirsty Gallacher will be joining Gold Radio next ...

A LEGENDARY radio soap opera has been licensed for a new play in Cirencester. The Archers has been licensed by the BBC for a play described as a ‘love letter’ to the soap. The long-running BBC Radio 4 ...

“Radio remains a gold standard to reaching people,” Batura from Focus said. “God has given us this platform and medium to communicate, whether it’s uplifting, inspirational type of ...

Houston-based Vertex Energy Inc . (OTC Pink:OTC:VTNRQ), a petroleum refining company with annual revenues of $3.2 billion, has received confirmation from the U.S. Bankruptcy Court for the Southern ...

Vertex Pharmaceuticals is trying to diversify its product portfolio. One of the programs it's working on aims to treat pain in a few contexts. There's reason to believe that it won't be effective ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...

NASA's Deep Space Network, an array of giant radio antennas, allows agency missions to track, send commands to, and receive scientific data from spacecraft venturing to the moon and beyond.

The creators of Gavin and Stacey took over the breakfast show, joined by several cast members ahead of the sitcom’s final episode. While fans hailed the takeover as "iconic" and urged the cast ...

Vertex Pharmaceuticals stock was heading for a double-digit gain this year until recent weeks. The company is approaching an important turning point -- one that could set the tone for revenue ...

Vertex Pharmaceuticals Inc.’s nonaddictive drug for lower back pain didn’t do better than a placebo in a midstage trial, causing the company’s shares to fall Thursday. Vertex, based in ...

(RTTNews) - Shares of Vertex Pharmaceuticals Inc. (VRTX) are falling on Thursday morning after its Phase 2 Study results using placebo showed improved or rather similar results, compared to the ...

Vertex Pharmaceuticals said Thursday that its closely watched drug, suzetrigine, reduced pain compared to baseline but did not outperform a placebo in a Phase 2 study, raising doubts about the ...